These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Study of single nucleotide polymorphism of SOCS gene in typical myeloproliferative neoplasms]. Qin W; Chen T; Yang JH; Zhang Y; Xiao R; Lu JT; Wang T; Zhou M; He JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1507-12. PubMed ID: 24370038 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders. Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760 [TBL] [Abstract][Full Text] [Related]
8. [Research advances on relationship between suppressor of cytokine signaling 3 and myeloproliferative neoplasms]. Qin W; Fu JF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1101-4. PubMed ID: 20723338 [TBL] [Abstract][Full Text] [Related]
10. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins. Linossi EM; Nicholson SE Immunol Rev; 2015 Jul; 266(1):123-33. PubMed ID: 26085211 [TBL] [Abstract][Full Text] [Related]
11. Research Advances on Suppressor of Cytokine Signaling 3 (SOCS3) in Animal Carbohydrate and Lipid Metabolism Processes. Liu W; Wang X Pak J Biol Sci; 2022 Nov; 25(12):1100-1108. PubMed ID: 36978278 [TBL] [Abstract][Full Text] [Related]